Accretion Nutraveda GMP IPO Date, Review, Price, Allotment Details IPO
Accretion Nutraveda IPO Summary
IPO Open Date: 28 Jan 2026
IPO Close Date: 30 Jan 2026
Price Band: ₹122 to ₹129 Per Share
Issue Size: Approx ₹24.77 Crores
Listing Exchange: BSE SME
Website: http://www.accretionnutraveda.com/
Accretion Nutraveda IPO Overview
Accretion Nutraveda IPO is a book build issue of ₹24.77 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹24.77 crore.
Accretion Nutraveda IPO opens for subscription on Jan 28, 2026 and closes on Jan 30, 2026. The allotment for the Accretion Nutraveda IPO is expected to be finalized on Feb 2, 2026. Accretion Nutraveda IPO will list on BSE SME with a tentative listing date fixed as Feb 4, 2026.
Accretion Nutraveda IPO price band is set at ₹122 to ₹129 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,58,000 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹3,87,000.
Accretion Nutraveda IPO Details
| Company Name | Accretion Nutraveda Ltd |
| IPO Open Date | 28 Jan 2026 |
| IPO Close Date | 30 Jan 2026 |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹122 to ₹129 Per Share |
| Issue Size | Approx ₹24.77 Crores |
| Fresh Issue | Approx ₹24.77 Crores |
| Offer for Sale | - |
| Issue Type | Book Build Issue |
| Listing On | BSE SME |
Accretion Nutraveda IPO Review & Key Points
NeutralAccretion Nutraveda IPO Market Lot
The Accretion Nutraveda IPO minimum market lot is 2,000 shares with ₹2,58,000 application amount.
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | ₹2,58,000 |
| Retail Maximum | 2 | 2,000 | ₹2,58,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,87,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,03,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,32,000 |
Accretion Nutraveda IPO Reservation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Anchor Investor | 5,46,000 Shares | 28.44% |
| QIB (Ex. Anchor) | 3,62,000 Shares | 18.85% |
| NII / HNI | 2,76,000 Shares | 14.37% |
| Retail | 6,40,000 Shares | 33.33% |
Anchor Bidding Date: 27 Jan 2026
Anchor Issue Size: 7.04 Cr.
30 Days Lock-in: 04 Mar 2026
90 Days Lock-in: 03 May 2026
Accretion Nutraveda IPO Dates & Allotment
The Accretion Nutraveda IPO date is January 28 and the close date is January 30. The Accretion Nutraveda IPO allotment will be finalized on February 2 and the IPO listing on February 4.
| IPO Opening Date | 28 Jan 2026 |
| IPO Closing Date | 30 Jan 2026 |
| Bidding Cutoff Time | 5 PM |
| Basis of Allotment | 02 Feb 2026 |
| Refunds Initiation | 03 Feb 2026 |
| Credit to Demat | 03 Feb 2026 |
| IPO Listing Date | 04 Feb 2026 |
Accretion Nutraveda IPO Objects of the Issue & Utilization of Proceeds
| Description | Amount |
|---|---|
| Purchase of Machineries for Automation in existing Manufacturing unit | ₹4.22 |
| Purchase of Machineries for New Manufacturing Setup | ₹8.03 |
| Funding working capital requirements of our company | ₹5.50 |
| General Corporate Purpose | ₹ |
Accretion Nutraveda Ltd Financials
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹3.07 | ₹2.78 | ₹0.28 | ₹4.06 |
| 2024 | ₹5.20 | ₹4.28 | ₹0.82 | ₹4.64 |
| 2025 | ₹16.06 | ₹12.87 | ₹2.61 | ₹10.86 |
| Sep 2025 | ₹14.07 | ₹11.20 | ₹2.33 | ₹16.35 |
Accretion Nutraveda IPO Valuation
Check Accretion Nutraveda IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Parameter | Value |
|---|---|
| Earnings Per Share (EPS) | ₹7.19 (Basic) |
| P/E Ratio | N/A |
| Return on Equity (ROE) | 81.22% |
| Return on Capital Employed (ROCE) | 36.98% |
| Return on Net Worth (RoNW) | 48.85% |
| Net Asset Value (NAV) | ₹14.72 |
| EBITDA Margin | 22.79% |
| PAT Margin | 16.33% |
Accretion Nutraveda IPO Peer Group Comparison
| Company | EPS | P/E | RoNW % | NAV | Total Income |
|---|---|---|---|---|---|
| Walpar Nutritions Ltd. | 1.80 | 23.94 | 11.27% | 13.65 | 60.26 Cr. |
| Influx Healthtech Limited | 7.31 | 25.93 | 36.72% | 5.31 | 104.99 Cr. |
Accretion Nutraveda IPO Promoters & Holding Pattern
The promoters of the company are Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel.
| Particulars | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 53,20,000 | 100% |
| Promoter Holding Post Issue | 72,40,000 | 73.48% |
Accretion Nutraveda IPO Lead Managers (Merchant Bankers)
- Sobhagya Capital Options Pvt. Ltd.
About Accretion Nutraveda Ltd
Accretion Nutraveda is a pioneering nutraceutical organization dedicated to bridging the gap between traditional Ayurvedic wisdom and modern clinical science. The company specializes in developing high-quality health supplements and wellness products designed to enhance holistic well-being and metabolic health. Since its inception, Accretion Nutraveda has established a robust market presence through rigorous quality standards and a diverse portfolio targeting core nutritional needs.
Accretion Nutraveda Ltd Address
TaSanand, Ahmedabad, Gujarat, 382213Phone: +91- 9904366177
Email: [email protected]
Accretion Nutraveda IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/